All In Biotech

Drug Trial Radar · NCT05502367

A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia

An Open-Label Single and Multiple-dose, Study to Evaluate Safety, Tolerability and Efficacy of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Squamous Intraepithelial Lesions

Last checked: Nov 19, 2026Latest source record: Feb 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

44

Actual

Start

Sep 10, 2022

Primary completion

Oct 27, 2025

Study completion Oct 27, 2025

Sponsor

Lead sponsor
Antiva BiosciencesIndustry
Sponsor type
Industry
First posted
Aug 16, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 25 years, up to 55 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label study to evaluate the safety, tolerability, and efficacy of ABI-2280 in participants with cervical squamous intraepithelial lesions. This study is divided into 2 parts - Part A and Part B. Part A consists of up to 9 dose escalation cohorts. Part B consists of dose expansion cohorts. Participants will self-administer ABI-2280.

Conditions

  • Cervical Intraepithelial Neoplasia

Interventions

  • ABI-2280 Vaginal Tablet/InsertDrug

    Vaginal Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Adverse Events (Safety and Tolerability)Time frame: From Baseline to Day 42 post dose administration

Locations

7 sites in 3 countries. Site status is shown where the registry gives one.

  • East Sydney Doctors

    Darlinghurst, New South Wales, Australia

  • CerviCusco

    Cusco, Peru

  • Ginobs S.A.

    Lima, Peru

  • Farmovs

    Bloemfontein, Free State, South Africa

  • Nafasi Integrated Solutions

    Sunnyside, Gauteng, South Africa

  • Botho ke Bontle Health Services

    Waltloo, Gauteng, South Africa

  • Gole Biomedical Research Centre

    Ga-Mothapo, Limpopo, South Africa

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.